We found that ICAM-1 expression was high in fibroblasts (i.e., mesenchymal cells of tumor tissue) of tumor tissue in patients with different clinical stages, which negatively correlated with patient survival, consistent with our results in vivo and in vitro. This evidence concerns the gene ICAM1 and neoplasm.